Dividendes sectoriels Elite Pharmaceuticals, Inc.
Actions
ELTP
US28659T2006
Produits pharmaceutiques
|
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 0,3601 USD | -0,25% |
|
-3,09% | -26,55% |
| 04/08 | Elite Pharmaceuticals annonce le lancement commercial de la version générique du Requip XL | CI |
| 30/06 | Transcript : Elite Pharmaceuticals, Inc., 2026 Earnings Call, Jun 30, 2026 |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Rendement du dividende (Y) | Rendement du dividende (Y+1) | PER (Y) | Price to Book (Y) | VE / CA (Y) | VE / EBITDA (Y) | VE / EBIT (Y) | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|
 | - | - | - | - | - | - | - | 388 M | |
| 0,88% | 1,02% | 35.88x | 5.03x | 6.74x | 23.35x | 28.24x | 48,92 Md | |
| 1,31% | 1,39% | 19.79x | 2.02x | 2.33x | 10.61x | 13.83x | 41,53 Md | |
| 0,89% | 1% | 28.57x | 3.16x | 3.48x | 18.05x | 23.15x | 12,43 Md | |
| 0,6% | 0,62% | 26.53x | 3.64x | 3.91x | 15.94x | 21.82x | 11,7 Md | |
| 3,85% | 3,94% | 18.73x | 3.25x | 3.33x | 11.58x | 13.79x | 9,09 Md | |
| 4,49% | 5,23% | 8.96x | 1.54x | 2.07x | 5.39x | 6.64x | 7,4 Md | |
| 3,24% | 3,21% | 15.92x | 1.29x | 2.06x | 6.44x | 9.69x | 7,15 Md | |
| 0,23% | 0,17% | 34.17x | 6.05x | 3.89x | 16.56x | 18.29x | 6,66 Md | |
| 0,95% | 0,95% | 41.82x | 9.61x | 8.01x | 29.72x | 33.18x | 4,59 Md | |
| 1,75% | 1,65% | 15.46x | 0.75x | 2.14x | 9.16x | 11.58x | 4,18 Md | |
| 3,33% | 3,84% | 15.96x | 2.61x | 2.58x | 12.01x | 11.64x | 4,04 Md | |
| 2,68% | 2,75% | 14.8x | 2.98x | 3.45x | 12.87x | 14.22x | 2,94 Md | |
| 3,17% | 3,52% | 18.99x | 5.09x | 5.92x | 16.83x | 18.2x | 2,63 Md | |
| Moyenne | 2,1% | 2,25% | 22,74x | 3,62x | 3,84x | 14,50x | 17,25x | 11,69 Md | |
| Moyenne pondérée par Capi. | 1,53% | 1,65% | 25,94x | 3,57x | 4,19x | 15,93x | 19,61x |
- Bourse
- Actions
- Action ELTP
- Secteur Elite Pharmaceuticals, Inc.
- Dividendes sectoriels
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
